Isolation of Lactobacillus acidophilus strain and its anti-obesity effect in a diet induced obese murine model

Lett Appl Microbiol. 2024 Mar 1;77(3):ovae021. doi: 10.1093/lambio/ovae021.

Abstract

Intestinal microbiota is a potential determinant of obesity, with probiotic bile salt hydrolase (BSH) as one of the key mechanisms in the anti-obesity effects. In this study, we present a Lactobacillus acidophilus GOLDGUT-LA100 (LA100) with high BSH activity, good gastric acid and bile salt tolerance, and a potential anti-obesity effect. LA100's anti-obesity effects were evaluated in a high-fat diet-induced, obese mouse model. LA100 administration alleviates high-fat diet-induced pathophysiological symptoms, such as body weight gain, high serum glucose and cholesterol level, hepatic lipid accumulation, and adipose inflammation. These results demonstrate concrete anti-obesity benefit in animal models and show promising applications in future clinical studies.

Keywords: Lactobacillus acidophilus; high-fat diet; obesity; probiotics.

MeSH terms

  • Animals
  • Diet, High-Fat
  • Disease Models, Animal
  • Lactobacillus acidophilus*
  • Mice
  • Mice, Inbred C57BL
  • Obesity
  • Probiotics* / pharmacology